| 4.54 0.65 (16.71%) | 11-21 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.19 |
1-year : | 7.23 |
| Resists | First : | 5.3 |
Second : | 6.19 |
| Pivot price | 4.39  |
|||
| Supports | First : | 4.34 |
Second : | 3.75 |
| MAs | MA(5) : | 4.11 |
MA(20) : | 4.44 |
| MA(100) : | 3.79 |
MA(250) : | 3.46 |
|
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 20.6 |
D(3) : | 9.5 |
| RSI | RSI(14): 54.4 |
|||
| 52-week | High : | 5.3 | Low : | 2.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SOPH ] has closed below upper band by 37.3%. Bollinger Bands are 25.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.71 - 4.73 | 4.73 - 4.76 |
| Low: | 3.85 - 3.88 | 3.88 - 3.91 |
| Close: | 4.49 - 4.54 | 4.54 - 4.58 |
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Thu, 13 Nov 2025
Rathbones Group PLC Takes Position in SOPHiA GENETICS SA $SOPH - MarketBeat
Tue, 11 Nov 2025
SOPHiA GENETICS (NASDAQ: SOPH) brings MSK assays to T1+ platform with up to 2B reads - Stock Titan
Tue, 11 Nov 2025
SOPHiA Genetics inks two deals to advance AI for precision medicine - Seeking Alpha
Mon, 10 Nov 2025
Sophia Genetics stock price target raised to $7 from $6 at BTIG - Investing.com
Sat, 08 Nov 2025
SOPHiA GENETICS Rides Genomics Wave Despite Ongoing Losses - Finimize
Wed, 05 Nov 2025
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q3 2025 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 68 (M) |
| Shares Float | 51 (M) |
| Held by Insiders | 6.4 (%) |
| Held by Institutions | 49.6 (%) |
| Shares Short | 138 (K) |
| Shares Short P.Month | 33 (K) |
| EPS | -1.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.88 |
| Profit Margin | -102.3 % |
| Operating Margin | -91.8 % |
| Return on Assets (ttm) | -25.6 % |
| Return on Equity (ttm) | -86.1 % |
| Qtrly Rev. Growth | 22.7 % |
| Gross Profit (p.s.) | 0.72 |
| Sales Per Share | 1.08 |
| EBITDA (p.s.) | -1.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -37 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | -4.06 |
| PEG Ratio | 0 |
| Price to Book value | 5.1 |
| Price to Sales | 4.2 |
| Price to Cash Flow | -8.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|